Showing 1651-1660 of 2054 results for "".
- Tilak Healthcare Launches US Pilot for OdySight Medical Vision Monitoring Apphttps://modernod.com/news/tilak-healthcare-launches-us-pilot-for-odysight-medical-vision-monitoring-app/2479202/Tilak Healthcare is launching a pilot program in the US with Novartis for OdySight, Tilak’s first clinically tested mobile app for patient remote vision monitoring. The program is the first to launch under an international collaboration announced in 2020 between Tilak Healthcare and
- AAO: Leading Advocates for Seniors’ Timely Access to Care Legislation Applaud Senate Bill Introductionhttps://modernod.com/news/aao-leading-advocates-for-seniors-timely-access-to-care-legislation-applaud-senate-bill-introduction/2478675/The Regulatory Relief Coalition (RRC), a group of national physician specialty organizations, announced its strong support for the Improving Seniors’ Timely Access to Care Act, legislation introduced today in the U.S. Senate by Senators Sherrod Brown (D-OH) and John Thune (R-SD). The
- Tilak Healthcare Partners With Novartis to Promote Mobile App OdySighthttps://modernod.com/news/tilak-healthcare-partners-with-novartis-in-ophthalmology/2478634/Tilak Healthcare, a provider of digital therapeutics, has announced an agreement with Novartis Pharma for the promotion internationally of OdySight, Tilak Healthcare’s first clinically validated mobile app for patient remote vision monitoring. Financial terms of the deal were not disclosed
- Lilly, Incyte’s Olumiant Cuts Recovery Time When Added to Veklury in Hospitalized COVID-19 Patientshttps://modernod.com/news/lilly-incytes-olumiant-cuts-recovery-time-when-added-to-veklury-in-hospitalized-covid-19-patients/2478281/Eli Lilly and Incyte reported Monday that the JAK1/JAK2 inhibitor Olumiant (baricitinib) in combination with Gilead Sciences’ Veklury (remdesivir) met the primary endpoint of the ACTT 2 study by significantly reducing the time to recovery compared to Veklury alone in hospitalized patients w
- Bascom Palmer Eye Institute Ranked Nation’s No. 1 in Ophthalmology for 19th Timehttps://modernod.com/news/bascom-palmer-eye-institute-ranked-nations-no-1-in-ophthalmology-for-19th-time/2478089/Bascom Palmer Eye Institute of the University of Miami Health System has been ranked again as the nation’s best in ophthalmology by U.S News & World Report. This year marks the 19th time, and the 17th consecutive year, that
- Alcon Survey Shows More Screen Time Causing Consumer Concern About Eye Health, Increasing Symptoms of Dry Eyehttps://modernod.com/news/alcon-survey-shows-more-screen-time-causing-consumer-concern-about-eye-health-increasing-symptoms-of-dry-eye/2478054/Alcon announced the results of a new survey, conducted by research firm Ipsos among 1,005 US adults, that uncover the impact the COVID-19 pandemic is having on consumers’ screen time and how that impacts their perceptions on eye health. Key findings include: Nearly 80% of Americans r
- FAH Demands More Time For Providers to Repay Advance Medicare Payments Due Soonhttps://modernod.com/news/fah-demands-more-time-for-providers-to-repay-advance-medicare-payments-due-soon/2477909/The Federation of American Hospitals is imploring Medicare to give providers more time to repay advanced Medicare loans sent out to help providers facing a financial crisis from COVID-19, according to a FierceHealthcare
- New York Times: Hospitals Got Bailouts and Furloughed Thousands While Paying CEOs Millionshttps://modernod.com/news/new-york-times-hospitals-got-bailouts-and-furloughed-thousands-while-paying-ceos-millions/2477874/The New York Times analyzed tax and securities filings by 60 of the country’s largest hospital chains, which have received a total of more than $15 billion in emergency funds through the economic stimulus package in the federal CARES Act.
- Clearside Biomedical Revises NDA Resubmission Timeline and Xipere Commercial Partnership with Bausch Healthhttps://modernod.com/news/clearside-biomedical-revises-nda-resubmission-timeline-and-xipere-commercial-partnership-with-bausch-health/2477660/Clearside Biomedical announced an update to the Xipere (triamcinolone acetonide suprachoroidal injectable suspension) new drug application (NDA) resubmission timeline and to its commercialization and development partnership with Bausch Health Companies and Bausch + Lomb.
- Allergan, Sightsavers, and the IAPB Announce the “Keep Sight” Initiative to Address Glaucoma in Ganjam, Odishahttps://modernod.com/news/allergan-sightsavers-and-the-iapb-announce-the-keep-sight-initiative-to-address-glaucoma-in-ganjam-odisha/2477318/Allergan, Sightsavers, and the International Agency for the Prevention of Blindness (IAPB) announced the launch of its unique joint initiative, ‘Keep Sight India,’ a community-based glaucoma screening program to prevent glaucoma-related vision loss in Ganjam District, Odisha. The pilot kicked off